Lumisterol
| Names | |
|---|---|
| IUPAC name
(22E)-9β,10α-Ergosta-5,7,22-trien-3β-ol | |
| Systematic IUPAC name
(1R,3aR,7S,9aS,9bR,11aR)-1-[(2R,3E,5R)-5,6-Dimethylhept-3-en-2-yl]-9a,11a-dimethyl-2,3,3a,6,7,8,9,9a,9b,10,11,11a-dodecahydro-1H-cyclopenta[a]phenanthren-7-ol | |
| Identifiers | |
3D model (JSmol) |
|
| ChemSpider | |
| ECHA InfoCard | 100.006.808 |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C28H44O | |
| Molar mass | 396.659 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
Lumisterol, more specifically lumisterol2 (L2), is a compound that is part of the vitamin D family of steroid compounds. It is the (9β,10α) stereoisomer of ergosterol and occurs as a photochemical by-product in the preparation of vitamin D1, a mixture of vitamin D2 and lumisterol. Lumisterol has an analog based on 7-dehydrocholesterol, known as lumisterol 3 or lumisterol3 (L3).